WO2026105063 - LONG-ACTING IL-15 AGONIST FOR TREATING BLADDER CANCER

National phase entry is expected:
Publication Number WO/2026/105063
Publication Date 21.05.2026
International Application No. PCT/IB2025/061669
International Filing Date 14.11.2025
Title **
[English] LONG-ACTING IL-15 AGONIST FOR TREATING BLADDER CANCER
[French] AGONISTE IL-15 À ACTION PROLONGÉE POUR LE TRAITEMENT DU CANCER DE LA VESSIE
Applicants **
SUZHOU FORLONG BIOTECHNOLOGY CO., LTD.
Inventors
JI, En
WEI, Duo
XU, Xiajun
Priority Data
PCT/CN2024/132036   14.11.2024   CN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2557
EPO Filing, Examination, Granting12190
Japan Filing, Examination, Granting2307
South Korea Filing, Examination, Granting2385
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 24,179
Contact Us
Abstract[English] A method of treating bladder cancer with an agonistic IL-15 complex, alone or in combination with BCG, is described.[French] L'invention concerne une méthode de traitement du cancer de la vessie au moyen d'un complexe IL-15 agoniste, seul ou en combinaison avec le BCG.